Actively Recruiting
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
Led by Shandong Suncadia Medicine Co., Ltd. · Updated on 2025-03-05
84
Participants Needed
1
Research Sites
22 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study mainly evaluated the safety and tolerability of HRS-1893 in subjects with non-obstructive hypertrophic cardiomyopathy, and the efficacy and plasma concentrations of different dosing regimens in subjects with non-obstructive hypertrophic cardiomyopathy.
CONDITIONS
Official Title
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 85 years old, male or female
- Body mass index less than 35 kg/m2
- Understand study procedures and voluntarily agree to participate and sign informed consent
- Female participants of childbearing potential must have a negative serum pregnancy test before first dose and must not be lactating
- Female participants of childbearing potential and male participants with partners of childbearing potential must agree to use contraception and refrain from donating sperm or eggs from consent until 3 months after last dose
You will not qualify if you...
- Known or suspected infiltration, hereditary, or storage disorders causing myocardial hypertrophy
- Paroxysmal atrial flutter or atrial fibrillation with clinical symptoms at screening
- History of syncope or sustained ventricular tachycardia within 6 months prior to screening
- Participation in any drug or medical device clinical trial within 3 months before screening
- Any other condition deemed unsuitable by the investigator for trial participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fuwai Hospital
Beijing, Beijing Municipality, China, 100032
Actively Recruiting
Research Team
J
Jianhong Lv
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here